What Types of Biomarkers are Used in Cancer Trials?
There are several types of biomarkers used in cancer trials, including: - Predictive Biomarkers: Indicate whether a patient is likely to benefit from a particular treatment. - Prognostic Biomarkers: Provide information about the likely course of the disease, regardless of treatment. - Pharmacodynamic Biomarkers: Show that a biological response has occurred in response to a treatment. - Surrogate Biomarkers: Substitute for a clinical endpoint, such as overall survival, in clinical trials.